Log In
BCIQ
Print this Print this
 

sabarubicin (MEN 10755)

  Manage Alerts
Collapse Summary General Information
Company Menarini Group
DescriptionAnthracycline analog
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationSmall cell lung cancer
Indication DetailsTreat small cell lung cancer (SCLC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today